Previous Article | Next Article ![]()
Infection and Immunity, September 2000, p. 5050-5055, Vol. 68, No. 9
Department of Microbiology and Molecular
Genetics, Harvard Medical School, Boston, Massachusetts 02115
Received 6 March 2000/Returned for modification 3 May 2000/Accepted 19 May 2000
Salmonella enterica serovar Typhimurium invasion genes
are necessary for bacterial invasion of intestinal epithelial cells and
are thought to allow salmonellae to enter and cross the intestinal epithelium during infection. Many invasion genes are encoded
on Salmonella pathogenicity island 1 (SPI1), and their
expression is activated by HilA, a transcription factor
also encoded on SPI1. We have studied the role of
Salmonella invasion genes during infection of mice
following intragastric inoculation. We have found that strains
containing a mutation in hilA or
invG were recovered from the intestinal contents,
intestinal tissues, and systemic tissues at a lower frequency than
their parental wild-type strain. In contrast, a strain in which SPI1 is
deleted was recovered from infected mice at a frequency similar to
that of its parental wild-type strain. The Infection with Salmonella
enterica serovar Typhimurium can cause a systemic, typhoid-like
disease in mice. Following ingestion, bacteria can colonize the
intestinal tract, penetrate the intestinal epithelium, and access
systemic sites such as the spleen and liver through the lymphatic and
blood circulation (7). Passage of the bacteria through the
intestinal wall is believed to be initiated by bacterial invasion into
enterocytes and M cells (7, 22, 26, 43). The ability of
salmonellae to penetrate the intestinal mucosa has been correlated with
their ability to invade cultured nonphagocytic cells (14, 17,
26). Salmonella invasion into cultured epithelial
cells is mediated by a bacterial type III secretion system
(25). Secretion of bacterial proteins such as SopE and SptP
into the host cell cytosol reorganizes the cytoskeleton, leading to
membrane ruffling and bacterial uptake (12, 13, 19, 28, 46).
The type III secretion system is encoded by genes on
Salmonella pathogenicity island 1 (SPI1) (33).
Expression of the SPI1 secretion system as well as many of its secreted
effectors are coordinately regulated by HilA, a transcriptional
activator encoded on SPI1 (1-3, 11).
Invasion genes appear to be important for serovar Typhimurium infection
of mice via the gastric route. Ligated loop assays have shown that
bacterial strains with mutations in hilA and other invasion
genes have a reduced ability to enter and disrupt M cells compared to
their wild-type (WT) parental strain (10, 26, 36). Studies
of the dose of bacteria required to kill 50% of infected mice (50%
lethal dose [LD50]) also suggest that invasion genes are
important for infection via the gastric route. The LD50 of
invasion mutants administered intraperitoneally (i.p.) is the same as
that of the WT, whereas the LD50 of invasion mutants
administered intragastrically (i.g.) is increased at least 20-fold over
that of the WT (1, 4, 14, 26, 36). In these studies, i.p. inoculation is thought to deliver bacteria directly to systemic sites
and bypass the need for invasion genes to traverse the intestinal wall.
The decrease in virulence of a hilA mutant and other
invasion mutants when inoculated i.g. but not i.p. suggests that
invasion genes are important for entering and crossing the intestinal epithelium.
Invasion genes also contribute to the ability of salmonellae to induce
migration of neutrophils (PMNs) into and across the intestinal
epithelium (15, 27, 31). A hallmark of gastroenteritis, this
transmigration response requires Salmonella adhesion to the epithelial apical membrane. Bacterial contact causes the epithelial cells to express and secrete chemokines that are chemotactic for PMNs
(30). In vitro studies have shown that hilA and
other SPI1 invasion genes are required for serovar Typhimurium to
induce cytokine expression and transepithelial migration of PMNs
(16). Invasion genes also appear to be involved in nitric
oxide production in cultured colonic epithelial cells. A
Salmonella enterica serovar Dublin mutant defective in
invA, which encodes a component of the SPI1 secretion
system, does not induce NO production compared to a WT strain. NO
production increases in response to stimulation with a combination of
gamma interferon and interleukin-1 or tumor necrosis factor alpha
(45 and references within). Thus, invasion factors
may enhance NO production by inducing the expression of these
cytokines. Interestingly, serovar Typhimurium may induce invasion and
the production of certain cytokines via the same mechanism. The
delivery of SopE, one of the type III secretion effectors, into COS-1
cells activates a CDC42-dependent signal transduction cascade
(19) which appears to stimulate both membrane ruffling and
expression of interleukin-8 (21). Invasion genes have also
been shown to be important for serovar Typhimurium to induce macrophage
apoptosis in vitro (8, 34). SipB, an SPI1-secreted protein,
directly interacts with and activates the proapoptosis enzyme caspase-1
in cultured macrophages (20).
In summary, invasion genes have the potential to contribute to many
aspects of Salmonella pathogenesis by allowing the bacteria to directly and indirectly alter the behavior of host cells, such as
epithelial cells, PMNs, and macrophages. Previous studies have primarily focused on investigating the role of invasion genes in
allowing salmonellae to enter and cross intestinal epithelial cells
during infection. We have explored the role of invasion genes during
Salmonella pathogenesis by studying three mutant strains Bacterial strains and growth conditions.
RM12, a clone of
SL1344, was tested for virulence in mice and used as the WT serovar
Typhimurium strain in this study (23). P22 was used to
transduce mutations into the parental RM12 strain. RM40 contains the
hilA::Tn5lacZY-080 (tet)
mutation which was transduced from EE658 (3). RM69 contains
the Animal infections.
Female BALB/c mice 6 to 8 weeks old
(Taconic Farms, Inc.) were given drinking water containing streptomycin
(5 mg/ml) for 24 h prior to infection. Fresh drinking water
containing antibiotic was supplied every 4 days for the duration of the
experiment. Animals were starved overnight prior to inoculation.
Bacterial inocula were prepared by centrifuging broth cultures and
resuspending the bacteria in phosphate-buffered saline (PBS); 0.1 ml of
the inoculum was delivered i.g. using a feeding needle (Harvard
Instruments). The CFU in each inoculum was determined by plating
dilutions on agar plates containing appropriate antibiotics.
LD50 and mean day to death.
To determine
LD50s, groups of four animals were infected with the
specified inocula (10, 100, 1,000, and 10,000 CFU) for each strain.
Animal deaths were recorded for 3 weeks, and the LD50 was
estimated by the Reed and Muench method (39). The mean day to death refers to the average time it took animals to die.
C.I.'s and single infections.
For competitive indices
(C.I.'s) and total bacterial counts (CFU), infected tissues were
harvested and homogenized in PBS, and dilutions were plated on LB-agar
plates containing streptomycin, tetracycline, kanamycin, or
chloramphenicol. Specifically, a fragment of the intestine
approximately corresponding to the ileum, three Peyer's patches
proximal to the cecum, mesenteric lymph nodes, and the spleen were
removed from infected animals. The intestinal segment was further
divided into tissue (intestine) and nontissue (contents) fractions by
extruding the luminal material within each segment. All bacterial
strains used are streptomycin resistant. All mutant strains used are
resistant to an additional antibiotic, such as kanamycin, tetracycline,
or chloramphenicol. Therefore, the WT CFU was estimated by subtracting
the sum of CFU on kanamycin, chloramphenicol, and tetracycline (sum of
CFU for mutant strains) from the CFU on streptomycin (CFU for all
strains). C.I.'s were determined for each tissue sample by dividing
mutant CFU by WT CFU.
Statistical analysis.
All statistical tests were done using
the Prism statistical analysis package (GraphPad Software, San Diego,
Calif.). C.I.'s were logarithmically transformed, and arithmetic means
were calculated and used for analysis. The 95% confidence interval for
the log10 C.I. of the mutants was compared to 0 (one-sample
t test). For the CFU comparisons, paired and unpaired
Student t tests were done for each tissue (mixed and single
infections, respectively). Mean day to death for the WT and
hilA::tet strains was compared by the
generalized Wilcoxon test.
The ability of salmonellae to infect experimental animals via the
i.g. route can be inconsistent (4). One explanation for this
unreliability is inhibition of Salmonella colonization by the resident intestinal flora. Germ-free mice have been seen to have an
LD50 1,000-fold lower than non-germ-free mice when infected with serovar Typhimurium (35). Reduction of microflora by
treatment with streptomycin also increases the susceptibility of mice
to infection by increasing the ability of salmonellae to colonize the
intestinal tract and translocate to the mesentery, spleen, and liver
(5, 32, 38). Similarly, we found that streptomycin treatment
of mice prior to i.g. inoculation increases the reproducibility of
infection and dramatically reduces the dose required for infection (data not shown).
The numbers of bacteria recovered from mice following infection can
vary greatly from animal to animal. One way of reducing this
variability is to perform mixed infections (4, 14). This
approach allows direct comparison of mutant strains and the WT strain
in the same animal. In addition to using the WT strain as an internal
standard, mixed infections have the advantage of reducing the number of
animals necessary for determining the infection phenotype of a mutant
bacterial strain.
Mixed infections.
Eight mice were infected with a total of
104 CFU containing a mixture of WT and three mutant
strains, a hilA::tet, a
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Invasion Genes Are Not Required for Salmonella
enterica Serovar Typhimurium To Breach the Intestinal Epithelium:
Evidence That Salmonella Pathogenicity Island 1 Has
Alternative Functions during Infection
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
SPI1 phenotype indicates
that S. enterica does not require invasion genes to cross
the intestinal epithelium and infect systemic tissues. This result has
forced us to reconsider the long-held belief that invasion genes
directly mediate bacterial infection of the intestinal mucosa and
traversion of the intestinal barrier during infection. Instead, our
results suggest that hilA is required for bacterial
colonization of the host intestine. The seemingly
contradictory phenotype of the
SPI1 mutant suggests that
deletion of another gene(s) encoded on SPI1 suppresses the hilA mutant defect. We propose a model for S. enterica pathogenesis in which hilA and invasion
genes are required for salmonellae to overcome a host clearance
response elicited by another SPI1 gene product(s).
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
one mutant containing a deletion of SPI1, one mutant
containing an insertion mutation in hilA, and one mutant
containing an insertion mutation in invG, a component of the
type III secretion apparatus encoded on SPI1. We have compared the
levels of mutant and WT bacteria recovered from different tissues
following intragastric inoculation of mice. Results from these
infection assays together with LD50 determinations and
other published results suggest that invasion genes may contribute to
Salmonella pathogenesis by mediating bacterial interactions
with nonepithelial cell types. We propose a model in which SPI1 is
involved in a complex cross-talk scheme between the bacteria and the host.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
spi1::kan mutation in which SPI1
was deleted and replaced by a kanamycin resistance marker
(41). The
spi1::kan
mutation was transduced from SD11 (41). RM50 contains the
invG::cam mutation, which was
transduced from SB201 (gift of Jorge Galán). All strains were
grown in Luria-Bertani (LB) according to Sambrook et al.
(40) without pH adjustment to saturation by rolling culture
tubes overnight at 37°C. CFU were determined on LB-agar plates
(40) containing 5 g of NaCl per liter plus streptomycin
(100 mg/liter), tetracycline (25 mg/liter), kanamycin (50 mg/liter), or
chloramphenicol (25 mg/liter) when appropriate.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
spi1::kan, and an
invG::cam mutant, in an
approximately 1:1:1:1 ratio (Fig. 1).
Tissues were harvested 5 days postinoculation, homogenized, diluted,
and plated on LB-agar plates containing antibiotics. All strains are
streptomycin resistant; therefore, to determine the WT CFU, the sum of
the mutant CFUs, as determined on agar plates containing tetracycline,
kanamycin, or chloramphenicol, was subtracted from the total
streptomycin-resistant CFU. The C.I. was determined as mutant
CFU/WT CFU and compared to 1 (one-sample t test).

View larger version (29K):
[in a new window]
FIG. 1.
Mean C.I. of mutant strains for different tissues at 5 days postinoculation. Eight mice were orally infected with a mixture of
WT and mutant strains in equal proportions. Tissues were harvested at 5 days postinoculation, homogenized, and plated on streptomycin,
tetracycline, kanamycin, or chloramphenicol. Mean C.I.'s were
determined as described in Materials and Methods. Each symbol is the
logarithm of C.I. Solid squares, C.I.'s for the
spi1::kan mutant; open circles,
C.I.'s for the hilA::tet mutant; solid
circles, C.I.'s for the invG::cam
mutant. Horizontal lines are the mean of the logarithm of C.I.'s. ns,
mean C.I. not significantly different from 1 (log C.I. = 0) (P > 0.05, one-sample t test). An asterisk indicates that a
mean C.I. is significantly different from 1 (log C.I. = 0) (P < 0.05, one-sample t test).
spi1::kan mutant and WT strains
were recovered at a similar frequency from all tissues at all times
postinoculation (P > 0.05, one-sample t
test). Although the recovery of the
spi1::kan mutant was not
significantly different from that of the WT, the calculated mean C.I.
was greater than 1 in the intestine, Peyer's patches, mesenteric lymph
nodes, and spleen.
Mixed versus single infections.
We were concerned that the
presence of different bacterial strains in the infected mice could
alter their virulence phenotypes. For example, the presence of WT
bacteria might suppress a virulence defect of the
spi1::kan mutant. In fact,
complementation of the invasion defect of an invE mutant
strain by WT bacteria has been reported to occur in vitro
(18). In addition, the WT and/or the
spi1::kan strain could compete for
host factors and reduce the recovery of the
hilA::tet mutant from a mixed
infection. To investigate these possibilities, we compared results from
mixed and single infections. Groups of four animals were inoculated with 105 CFU of a single strain or 105 CFU of a
1:1 mixture of strains. Tissues were harvested 5 days postinoculation.
spi1::kan mutant, on the
other hand, was recovered at a similar frequency to the WT from all
tissues in both single and mixed infections (P > 0.05, unpaired t test and paired t test, respectively)
(Fig. 2B). These results suggest there is no
trans-complementation of the
spi1::kan mutant by WT bacteria
during a mixed infection and that the reduced recovery of the
hilA::tet mutant is not dependent on
coinfection with the WT strain.
|
Intestinal wall versus content.
We were interested in knowing
if the reduced recovery of the
hilA::tet mutant in the intestinal wall
(Fig. 1 and 2A) might be due to reduced colonization in the luminal
fraction of the intestine. We also wanted to know if the
spi1::kan mutant was able to
colonize the intestinal lumen as well as it could colonize the
intestinal tissue. Groups of four animals were infected with a mixture
of 105 CFU of WT and a mutant (the
hilA::tet or
spi1::kan mutant) in an
approximately 1:1 ratio. A fragment of the small intestine corresponding to the ileum was harvested at 5 days postinoculation. The
intestinal contents and wall were homogenized separately and plated.
Figure 3 shows the C.I.'s for both the
hilA::tet and
spi1::kan mutants in these samples.
The mean C.I. for the hilA::tet mutant is significantly less than 1 for both the intestinal wall and contents
(P < 0.05, one-sample t test). The mean
C.I. for the
spi1::kan mutant is not
significantly different from 1 for both the intestinal wall and
contents (P > 0.05, one-sample t test). There was no significant difference between the C.I.'s for each mutant
strain in the intestinal wall versus the intestinal contents (P > 0.05, paired t test).
|
LD50 and mean day to death.
We obtained
LD50 and mean day to death values for the WT,
spi1::kan, and
hilA::tet strains using the Reed-Muench
method (39) (Table 1). We
infected four groups of four animals with 10, 100, 1,000, and 10,000 CFU and recorded deaths for 3 weeks. Mean day to death was determined
as the average time it took mice to die at each dose.
|
spi1::kan mutant is at least
1,000-fold higher than the LD50 for the WT strain. This
result was surprising in light of our C.I. data showing that the
spi1::kan mutant is able to infect mice as efficiently as WT at 5 days postinoculation.
The mean day to death at the LD50 for the
hilA::tet mutant was higher than that
for the WT strain (14 versus 9 days), although this difference was not
statistically significant (P > 0.05, generalized Wilcoxon test). The mean day to death at the LD50 for the
spi1::kan mutant was approximately
the same as that for the hilA::tet mutant.
| |
DISCUSSION |
|---|
|
|
|---|
We have shown that invasion genes encoded on SPI1 are not necessary for serovar Typhimurium to enter and cross the intestinal wall. In addition, we have shown that invasion genes are important for bacterial colonization of the intestinal lumen. Our results suggest that deletion of a gene(s) on SPI1 suppresses the infection defect of the hilA and invG mutants. As discussed below, we propose that an SPI1-encoded factor stimulates host clearance responses in the intestine. In this model, invasion genes allow salmonellae to colonize the intestine by counteracting this host clearance response, possibly by causing the apoptosis of luminal phagocytes.
After i.g. inoculation, hilA and invG mutants are less able than a WT strain to infect intestinal and systemic tissues. By examining the contents of the intestinal lumen, we found that a mutation in hilA also reduces the recovery of salmonellae from the nontissue fraction of the ileum. Thus, hilA appears to be important for serovar Typhimurium to colonize the extracellular, luminal compartment of the intestine. Therefore, the reduced numbers of the hilA mutant found in the intestinal wall and systemic tissues might be the direct result of the reduced numbers of mutant bacteria present in the intestinal lumen.
Ligated loop assays have shown that invasion genes can be important for Salmonella entry into enterocytes, M cells, and Peyer's patches (9, 26, 36). Unfortunately, because ligated loop assays are so short, certain processes that affect bacterial colonization in vivo, such as bacterial replication and host clearance responses, cannot be assessed in these assays. Therefore, our finding that a hilA mutant exhibits an intestinal lumen colonization defect suggests that further work must be done to determine the relevance of the events observed during ligated loop assays for Salmonella pathogenesis in the murine model.
Several mechanisms might account for the hilA colonization defect. The hilA mutant might not adhere to or replicate at the mucosal surface. Another possibility is that the hilA mutant does not colonize the intestine because it is susceptible to bactericidal host factors such as phagocytes. Invasion genes have been found to be important for the ability of salmonellae to kill phagocytes in vitro (8, 20, 34). As discussed below, we favor the idea that the hilA mutant is defective in colonization because it is killed by phagocytes in the intestine.
Since we observed an infection defect in the hilA::tet mutant 5 days postinoculation, it was surprising that the LD50 for this mutant was indistinguishable from that for the WT strain. However, although the hilA mutant is defective for infection at early times postinoculation, we have observed that after a delay, the hilA mutant can be recovered from systemic tissues at levels similar to those of the WT strain (data not shown). Invasion gene-independent mechanisms may ultimately allow the hilA mutant to enter nonphagocytic cells, infect systemic sites, and kill mice. In vitro studies suggest that salmonellae possess invasion factors in addition to those encoded on SPI1. Stone et al. have described two classes of mutations that reduce Salmonella enterica serovar Enteritidis entry into nonphagocytic cells and that do not map to SPI1 (42). Hong and Miller have reported that SigD, which is normally secreted by the SPI1 type III secretion system, contributes to a serovar Typhimurium invasion mechanism that can operate independently of invA (24). Ligated loop assays with invA and invG mutant strains suggest that under certain circumstances, invasion genes are not necessary for invasion into M cells (10). In addition, serovar Typhimurium might enter enterocytes and M cells via a receptor, in a similar fashion to CFTR-dependent entry of Salmonella enterica serovar Typhi into epithelial cells (37). Alternatively, we favor the idea that bacterial entry into epithelial and M cells may be unnecessary for infection of the intestinal mucosa and systemic sites. In fact, in the absence of invasion genes, salmonellae appear to be shuttled from the intestine to the bloodstream within CD18-expressing phagocytes (44).
Our LD50 results contrast with other findings showing that
the i.g. LD50 for a hilA mutant strain is 10- to
50-fold higher than that for the WT strain (1, 36). One
possible explanation for the difference between our LD50
results and previous reports is that we used a streptomycin-treated
mouse model. While the LD50 for WT salmonellae has been
reported to be between 104 and 105 CFU (1,
14, 36), streptomycin treatment reduces the LD50 to
10. We speculate that killing of resident intestinal microflora by
streptomycin might enhance phagocyte migration into the intestinal lumen and therefore shuttling of bacteria from the intestine to systemic sites (44). Thus, streptomycin treatment may affect Salmonella infection in two ways
by reducing competition
with the intestinal microflora and by increasing the contribution of phagocytes to systemic infection.
The most intriguing results we have obtained are from our infection
studies with the
spi1 mutant. This mutant strain was recovered at a frequency similar to that of the WT strain from all
tissues. This result is surprising because the
spi1
mutant lacks the hilA gene and so was expected to have an
infection defect similar to that of the hilA mutant. Our
results suggest that deletion of an SPI1 gene(s) in the
spi1 strain suppresses the hilA infection defect and allows the salmonellae to colonize and infect their host in
an SPI1-independent manner. We favor a model in which a
hilA-independent SPI1 factor(s) stimulates a host clearance response that the bacteria can overcome by expressing a
hilA-dependent factor(s).
It is also surprising that the
spi1 strain can infect the
intestinal mucosa and spread to systemic sites efficiently because, like other invasion mutants, the
spi1 strain is not able
to enter HEp-2 cells in vitro (S. Damrauer and C. Lee, unpublished
results). However, as discussed above, invasion gene-independent
mechanisms for bacterial penetration of the intestinal epithelium might
account for the ability of the
spi1 mutant to infect
intestinal and systemic tissues.
Our result showing an increased LD50 for the
spi1 mutant was surprising considering the high recovery
of this mutant in systemic tissues 5 days postinoculation. The number
of Salmonella bacteria present at systemic sites is usually
directly correlated with disease and death. One explanation for our
results is that the
spi1 strain might not induce certain
host responses and consequently might not damage the host to the same
degree as the WT strain. Interestingly, Khan et al. have reported that
a waaN mutant strain defective in lipid A acylation is
recovered at very high numbers in the spleens and livers of infected
mice but does not induce cytokine expression, tissue damage, or death
(29). In addition, the waaN mutant strain is
ultimately cleared from the spleen and liver of infected animals. The
spi1 mutant might similarly be cleared at later times
postinoculation. In this case, SPI1 genes might be important for
persistence of salmonellae at systemic sites.
Model for the contribution of SPI1 genes to virulence.
We
propose a working model to explain why invasion genes are important for
bacterial colonization and persistence in the intestine (Fig.
4). Our model attempts to consider
current ideas about the role of invasion genes in protein translocation
and stimulation of host cell signal transduction as well as their
potential role in altering epithelial cell, neutrophil, and macrophage
biology. The infection phenotypes of the WT and invG,
hilA, and
spi1 mutant strains can be explained
by speculating that three important events occur when serovar
Typhimurium infects its murine host (Fig. 4). Analogous to elicitins
and avirulence factors of plant pathogens (6, 47),
Salmonella spp. express a hilA-independent SPI1 product that elicits a defense response in its host. The SPI1 elicitin
may recruit or activate intestinal phagocytes which can clear the
infection. However, expression of SPI1 invasion genes allows the
bacteria to overcome the host clearance response, possibly by
triggering apoptosis of the phagocytes in the intestinal lumen. Our
results suggest that the host response is stimulated by the expression
of an SPI1 elicitin gene(s) that is present in the WT, invG,
and hilA strains but deleted in the
spi1
strain. Although the WT strain and the hilA and
invG mutants trigger the host defense mechanism, only the WT
strain can successfully infect the host because it can express invasion
genes and counteract the host response in the third step. In this
scenario, the hilA and invG mutants are cleared
by the recruited or activated phagocytes. In contrast, even in the
absence of hilA, the
spi1 strain can infect
the host because it expresses no SPI1 elicitin and does not trigger
host clearance mechanisms.
|
| |
ACKNOWLEDGMENTS |
|---|
We thank members of the Lee lab, M. Starnbach, D. Schauer, N. Mantis, and J. Mekalanos for critical reading and helpful discussion of the manuscript. We thank S. D'Orazio, K. Klose, D. Schauer, M. Starnbach, and L. Steele for providing R.M. with technical advice. We thank S. Damrauer for technical assistance with the LD50 experiments. We thank Jorge Galán for providing us with strain SB201.
This work was funded by NIH (R01-AI33444). R.M. was supported by a Graduate Prize Fellowship scholarship and funds from the Harvard School of Public Health Division of Biological Sciences-Biological Sciences in Public Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-4988. Fax: (617) 738-7664. E-mail: clee{at}hms.harvard.edu.
Editor: A. D. O'Brien
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ahmer, B. M., J. van Reeuwijk, P. R. Watson, T. S. Wallis, and F. Heffron. 1999. Salmonella SirA is a global regulator of genes mediating enteropathogenesis. Mol. Microbiol. 31:971-982[CrossRef][Medline]. |
| 2. | Bajaj, V., C. Hwang, and C. A. Lee. 1995. hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes. Mol. Microbiol. 18:715-727[CrossRef][Medline]. |
| 3. | Bajaj, V., R. L. Lucas, C. Hwang, and C. A. Lee. 1996. Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol. Microbiol. 22:703-714[CrossRef][Medline]. |
| 4. | Bäumler, A. J., R. M. Tsolis, P. J. Valentine, T. A. Ficht, and F. Heffron. 1997. Synergistic effect of mutations in invA and lpfC on the ability of Salmonella typhimurium to cause murine typhoid. Infect. Immun. 65:2254-2259[Abstract]. |
| 5. | Bohnhoff, M., B. L. Drake, and C. P. Miller. 1954. Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc. Soc. Exp. Biol. Med. 86:132-139. |
| 6. | Bonas, U., and G. Van den Ackerveken. 1999. Gene-for-gene interactions: bacterial avirulence proteins specify plant disease resistance. Curr. Opin. Microbiol. 2:94-98[CrossRef][Medline]. |
| 7. | Carter, P. B., and F. M. Collins. 1974. The route of enteric infection in normal mice. J. Exp. Med. 139:1189-1203[Abstract]. |
| 8. | Chen, L. M., K. Kaniga, and J. E. Galán. 1996. Salmonella spp. are cytotoxic for cultured macrophages. Mol. Microbiol. 21:1101-1115[CrossRef][Medline]. |
| 9. |
Clark, M. A.,
B. H. Hirst, and M. A. Jepson.
1998.
Inoculum composition and Salmonella pathogenicity island 1 regulate M-cell invasion and epithelial destruction by Salmonella typhimurium.
Infect. Immun.
66:724-731 |
| 10. | Clark, M. A., K. A. Reed, J. Lodge, J. Stephen, B. H. Hirst, and M. A. Jepson. 1996. Invasion of murine intestinal M cells by Salmonella typhimurium inv mutants severely deficient for invasion of cultured cells. Infect. Immun. 64:4363-4368[Abstract]. |
| 11. |
Eichelberg, K., and J. E. Galán.
1999.
Differential regulation of Salmonella typhimurium type III secreted proteins by pathogenicity island 1 (SPI1)-encoded transcriptional activators InvF and HilA.
Infect. Immun.
67:4099-4105 |
| 12. | Fu, Y., and J. E. Galán. 1999. A Salmonella protein antagonizes Rac-1 and Cdc 42 to mediate host-cell recovery after bacterial invasion. Nature 401:293-297[CrossRef][Medline]. |
| 13. | Fu, Y., and J. E. Galán. 1998. The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton. Mol. Microbiol. 27:359-368[CrossRef][Medline]. |
| 14. |
Galan, J. E., and R. Curtiss, III.
1989.
Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells.
Proc. Natl. Acad. Sci. USA
86:6383-6387 |
| 15. | Galyov, E. E., M. W. Wood, R. Rosqvist, P. B. Mullan, P. R. Watson, S. Hedges, and T. S. Wallis. 1997. A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol. Microbiol. 25:903-912[CrossRef][Medline]. |
| 16. |
Gewirtz, A. T.,
A. M. Siber,
J. L. Madara, and B. A. McCormick.
1999.
Orchestration of neutrophil movement by intestinal epithelial cells in response to Salmonella typhimurium can be uncoupled from bacterial internalization.
Infect. Immun.
67:608-617 |
| 17. | Giannella, R. A., O. Washington, P. Gemski, and S. B. Formal. 1973. Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella. J. Infect. Dis. 128:69-75[Medline]. |
| 18. |
Ginocchio, C.,
J. Pace, and J. E. Galán.
1992.
Identification and molecular characterization of a Salmonella typhimurium gene involved in triggering the internalization of salmonellae into cultured epithelial cells.
Proc. Natl. Acad. Sci. USA
89:5976-5980 |
| 19. | Hardt, W. D., L. M. Chen, K. E. Schuebel, X. R. Bustelo, and J. E. Galán. 1998. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93:815-826[CrossRef][Medline]. |
| 20. |
Hersh, D.,
D. M. Monack,
M. R. Smith,
N. Ghori,
S. Falkow, and A. Zychlinsky.
1999.
The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1.
Proc. Natl. Acad. Sci. USA
96:2396-2401 |
| 21. | Hobbie, S., L. M. Chen, R. J. Davis, and J. E. Galán. 1997. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J. Immunol. 159:5550-5559[Abstract]. |
| 22. |
Hohmann, A. W.,
G. Schmidt, and D. Rowley.
1978.
Intestinal colonization and virulence of Salmonella in mice.
Infect. Immun.
22:763-770 |
| 23. | Hoiseth, S. K., and B. A. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239[CrossRef][Medline]. |
| 24. |
Hong, K. H., and V. L. Miller.
1998.
Identification of a novel Salmonella invasion locus homologous to Shigella ipgDE.
J. Bacteriol.
180:1793-1802 |
| 25. |
Hueck, C. J.
1998.
Type III protein secretion systems in bacterial pathogens of animals and plants.
Microbiol. Mol. Biol. Rev.
62:379-433 |
| 26. |
Jones, B. D.,
N. Ghori, and S. Falkow.
1994.
Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.
J. Exp. Med.
180:15-23 |
| 27. |
Jones, M. A.,
M. W. Wood,
P. B. Mullan,
P. R. Watson,
T. S. Wallis, and E. E. Galyov.
1998.
Secreted effector proteins of Salmonella dublin act in concert to induce enteritis.
Infect. Immun.
66:5799-5804 |
| 28. | Kaniga, K., J. Uralil, J. B. Bliska, and J. E. Galán. 1996. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol. Microbiol. 21:633-641[CrossRef][Medline]. |
| 29. | Khan, S. A., P. Everest, S. Servos, N. Foxwell, U. Zahringer, H. Brade, E. T. Rietschel, G. Dougan, I. G. Charles, and D. J. Maskell. 1998. A lethal role for lipid A in Salmonella infections. Mol. Microbiol. 29:571-579[CrossRef][Medline]. |
| 30. |
McCormick, B. A.,
S. P. Colgan,
C. Delp-Archer,
S. I. Miller, and J. L. Madara.
1993.
Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils.
J. Cell Biol.
123:895-907 |
| 31. |
McCormick, B. A.,
P. M. Hofman,
J. Kim,
D. K. Carnes,
S. I. Miller, and J. L. Madara.
1995.
Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils.
J. Cell Biol.
131:1599-1608 |
| 32. | Miller, C. P., and M. Bohnhoff. 1963. Changes in the mouse's enteric microflora associated with enhanced susceptibility to Salmonella infection following streptomycin treatment. J. Infect. Dis. 113:59-66[Medline]. |
| 33. | Mills, D. M., V. Bajaj, and C. A. Lee. 1995. A 40 kb chromosomal fragment encoding Salmonella typhimurium invasion genes is absent from the corresponding region of the Escherichia coli K-12 chromosome. Mol. Microbiol. 15:749-759[CrossRef][Medline]. |
| 34. |
Monack, D. M.,
B. Raupach,
A. E. Hromockyj, and S. Falkow.
1996.
Salmonella typhimurium invasion induces apoptosis in infected macrophages.
Proc. Natl. Acad. Sci. USA
93:9833-9838 |
| 35. | Nardi, R. M., M. E. Silva, E. C. Vieira, E. A. Bambirra, and J. R. Nicoli. 1989. Intragastric infection of germfree and conventional mice with Salmonella typhimurium. Braz. J. Med. Biol. Res. 22:1389-1392[Medline]. |
| 36. | Penheiter, K. L., N. Mathur, D. Giles, T. Fahlen, and B. D. Jones. 1997. Non-invasive Salmonella typhimurium mutants are avirulent because of an inability to enter and destroy M cells of ileal Peyer's patches. Mol. Microbiol. 24:697-709[CrossRef][Medline]. |
| 37. | Pier, G. B., M. Grout, T. Zaidi, G. Meluleni, S. S. Mueschenborn, G. Banting, R. Ratcliff, M. J. Evans, and W. H. Colledge. 1998. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393:79-82[CrossRef][Medline]. |
| 38. |
Que, J. U., and D. J. Hentges.
1985.
Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice.
Infect. Immun.
48:169-174 |
| 39. | Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497. |
| 40. | Sambrook, J., E. F. Fritsch, and T. Maniatis (ed.). 1989. Molecular cloning: a laboratory manual, 2nd ed., vol. 3. Cold Spring Harbor Laboratory Press, Plainview, N.Y. |
| 41. | Schechter, L. M., S. M. Damrauer, and C. A. Lee. 1999. Two AraC/XylS family members can independently counteract the effect of repressing sequences upstream of the hilA promoter. Mol. Microbiol. 32:629-642[CrossRef][Medline]. |
| 42. |
Stone, B. J.,
C. M. García,
J. L. Badger,
T. Hassett,
R. I. Smith, and V. L. Miller.
1992.
Identification of novel loci affecting entry of Salmonella enteritidis into eukaryotic cells.
J. Bacteriol.
174:3945-3952 |
| 43. | Takeuchi, A. 1967. Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium. Am. J. Pathol. 50:109-136[Medline]. |
| 44. | Vázquez-Torres, A., J. Jones-Carson, A. J. Bäumler, S. Falkow, R. Valdivia, W. Brown, M. Le, R. Berggren, W. T. Parks, and F. C. Fang. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-808[CrossRef][Medline]. |
| 45. |
Witthoft, T.,
L. Eckmann,
J. M. Kim, and M. F. Kagnoff.
1998.
Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells.
Am. J. Physiol.
275:G564-G571 |
| 46. | Wood, M. W., R. Rosqvist, P. B. Mullan, M. H. Edwards, and E. E. Galyov. 1996. SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a sip-dependent mechanism and promotes bacterial entry. Mol. Microbiol. 22:327-338[CrossRef][Medline]. |
| 47. |
Yu, L. M.
1995.
Elicitins from Phytophthora and basic resistance in tobacco.
Proc. Natl. Acad. Sci. USA
92:4088-4094 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»